The company said it has been granted one product patent from Australia, two product patents from Japan and one product patent from Hong Kong corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases.
Pharmaceutical firm Suven Life Sciences has been granted four product patents, one each by Australia and Hong Kong and two by Japan for treatment of neurodegenerative diseases. Neurodegenerative diseases include Alzheimer's disease, Schizophrenia and Parkinson's disease.
In a BSE filing, the company said it has been "granted one product patent from Australia, two product patents from Japan and one product patent from Hong Kong corresponding to the New Chemical Entity (NCE) for the treatment of disorders associated with Neurodegenerative diseases." These patents are valid through 2030, the company said.
Suven Life Sciences CEO Venkat Jasti said: "We are very pleased by the grant of these patents to Suven for our pipeline of molecules in CNS (central nervous system) arena that are being developed for Major Depressive Disorder (MDD) with high unmet medical need with huge market potential globally." With these new patents, Suven has a total of 19 granted patents from Australia, 14 from Japan and 15 from Hong Kong.
Suven Life Sci stock price
On January 20, 2015, Suven Life Sciences closed at Rs 220.70, up Rs 13.05, or 6.28 percent. The 52-week high of the share was Rs 236.50 and the 52-week low was Rs 67.50.
The company's trailing 12-month (TTM) EPS was at Rs 10.09 per share as per the quarter ended September 2014. The stock's price-to-earnings (P/E) ratio was 21.87. The latest book value of the company is Rs 20.86 per share. At current value, the price-to-book value of the company is 10.58.
Anda sedang membaca artikel tentang
Suven Life Sciences gets patents for neurodegenerative drug
Dengan url
http://kebugaranhidup.blogspot.com/2015/01/suven-life-sciences-gets-patents-for.html
Anda boleh menyebar luaskannya atau mengcopy paste-nya
Suven Life Sciences gets patents for neurodegenerative drug
namun jangan lupa untuk meletakkan link
Suven Life Sciences gets patents for neurodegenerative drug
sebagai sumbernya
0 komentar:
Posting Komentar